Atsauces

Sulakvelidze A., Alavidze Z., Morris J.G. 2001. Bacteriophage Therapy. – Antimicrobial Agents and Chemotheraphy, 45 (3): 649–659.
Fiers W. 1979. Structure and function of RNA bacteriophages. – In: Fraenkel-Conrat H., Wagner R.R. “Comprehensive Virology”, New York, Plenum Press: 69-204.
Alberts B., Bray D., Lewis J., Raff M., Roberts K., Watson J.D. 1994. Molecular biology of the cell. Third edition. New York: Garland Publishing, 1408 pp.
Fields B.N., Knipe D.M., Howley P.M. 1996. Fundamental virology. Third Edition. Philadelphia: Lippincott-Raven publishers, 1640 pp.
Дишлер А.В., Пумпен П.П., Грен Э.Я. 1982. Регуляция синтеза РНК и регуляторные мутанты у РНК-фагов. – В: Бактериофаги. Сборник научных трудов. Пущино: ОНТИ НЦБИ АН СССР, 76 – 82.
Pumpens P., Grens E. 2003. Artificial genes for chimeric virus-like particles. – In: Artificial DNA: methods and application, Florida, CRC Press: 250-327.
Strelnikova A. 1997. Development of recombinant RNA packaging vectors on the basis of bacteriophage Qβ. Ms. Sci. dissertation thesis. Riga, University of Latvia, 76 pp.
Reseviča G. 2004. Rīsu dzelteno raibumu vīrusiem līdzīgās daļiņas – iegūšana un īpašības. Maģistra darbs. Rīga, Latvijas Universitāte, 74 lpp.
Brown W.L., Mastico R.A., Wu M., Heal K.G., Adams C.J., Murray J.B., Simpson J.C., Lord J.M., Taylor-Robinson A.W., Stockley P.G. RNA bacteriophage capsid-mediated drug delivery and epitope presentation.
Hartmann G., Krieg A.M. 2000. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. – The Journal of Immunology, 164: 944–952.
Weiner G.J., Hsin-Ming L., Wooldridge J.E., Dahle C.E., Krieg A.M. 1997. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. – Proceedings of National Academy of Science USA, 94: 10833–37.
Vasiljeva I., Kozlovska T., Cielens I., Strelnikova A., Kazaks A., Ose V., Pumpens P. 1998. Mosaic Qβ coats as a new presentation model. – FEBS Letters, 431: 7-11.
Shestakova I., Domracheva I., Shkutele S., Ose-Klinklava V., Renhofa R. 2005. Interaction of mosaic virus-like particles carrying HBV preS sequences with cell surface in cultures: Do these epitopes work as specific addresses? – In: Riga meeting on comprehensive cell biology, Riga, June 2-4, 2005.
Kozlovska T.M., Cielēns I., Dreiliņa D., Dišlers A., Baumanis V., Ose V. and Pumpēns P. 1993. Recombinant RNA phage Qβ capsid synthesized and self-assembled in Escherichia coli. – Gene, 137: 133-137.

Autors un lapas izveides datums

Sākumlapa

Autors: Arnis Strods
e-pasts: astrods@gmail.com

Lapas pēdējais modificēšanas datums:
23.01.2006, 18:39

Atsauces

Sulakvelidze A., Alavidze Z., Morris J.G. 2001. Bacteriophage Therapy. – Antimicrobial Agents and Chemotheraphy, 45 (3): 649–659.

Fiers W. 1979. Structure and function of RNA bacteriophages. – In: Fraenkel-Conrat H., Wagner R.R. “Comprehensive Virology”, New York, Plenum Press: 69-204.

Alberts B., Bray D., Lewis J., Raff M., Roberts K., Watson J.D. 1994. Molecular biology of the cell. Third edition. New York: Garland Publishing, 1408 pp.

Fields B.N., Knipe D.M., Howley P.M. 1996. Fundamental virology. Third Edition. Philadelphia: Lippincott-Raven publishers, 1640 pp.

Pumpens P., Grens E. 2003. Artificial genes for chimeric virus-like particles. – In: Artificial DNA: methods and application, Florida, CRC Press: 250-327.

Strelnikova A. 1997. Development of recombinant RNA packaging vectors on the basis of bacteriophage Qβ. Ms. Sci. dissertation thesis. Riga, University of Latvia, 76 pp.

Reseviča G. 2004. Rīsu dzelteno raibumu vīrusiem līdzīgās daļiņas – iegūšana un īpašības. Maģistra darbs. Rīga, Latvijas Universitāte, 74 lpp.

Brown W.L., Mastico R.A., Wu M., Heal K.G., Adams C.J., Murray J.B., Simpson J.C., Lord J.M., Taylor-Robinson A.W., Stockley P.G. RNA bacteriophage capsid-mediated drug delivery and epitope presentation.

Hartmann G., Krieg A.M. 2000. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. – The Journal of Immunology, 164: 944–952.

Weiner G.J., Hsin-Ming L., Wooldridge J.E., Dahle C.E., Krieg A.M. 1997. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. – Proceedings of National Academy of Science USA, 94: 10833–37.

Vasiljeva I., Kozlovska T., Cielens I., Strelnikova A., Kazaks A., Ose V., Pumpens P. 1998. Mosaic Qβ coats as a new presentation model. – FEBS Letters, 431: 7-11.

Shestakova I., Domracheva I., Shkutele S., Ose-Klinklava V., Renhofa R. 2005. Interaction of mosaic virus-like particles carrying HBV preS sequences with cell surface in cultures: Do these epitopes work as specific addresses? – In: Riga meeting on comprehensive cell biology, Riga, June 2-4, 2005.

Kozlovska T.M., Cielēns I., Dreiliņa D., Dišlers A., Baumanis V., Ose V. and Pumpēns P. 1993. Recombinant RNA phage Qβ capsid synthesized and self-assembled in Escherichia coli. – Gene, 137: 133-137.